Kronox Lab Sciences Ltd

Kronox Lab Sciences Ltd

$KRONOXSpecialty ChemicalsNSEBSE

Kronox Lab Sciences Ltd (KRONOX) last traded at ₹186, a market capitalisation of ₹690 crore, on a P/E of 24.1. Over the past 52 weeks the stock has ranged between ₹96 and ₹223. Kronox Lab Sciences Ltd last reported results for the quarter ended Jun 2026, with sales of ₹28.39 crore and net profit of ₹7.3 crore. Kronox Lab Sciences Ltd’s annual general meeting is scheduled for 16 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Kronox Lab Sciences Ltd share price and key metrics

Current price
₹186
Market cap
₹690 cr
Stock P/E
24.1
Book value
₹31.3
ROE
26.8%
ROCE
36.0%
Dividend yield
0.25%
52w high / low
223/96.0

Metrics as of 25 Aug 2026. Not real time.

Kronox Lab Sciences Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹28.39 cr, up 16.9% from ₹24.29 cr a year earlier. Net profit was ₹7.3 cr, up 16.2% year on year.

Kronox Lab Sciences Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales24.8624.0126.1324.2925.5325.2726.1328.39
Expenses16.0615.6518.3816.3216.8817.2416.6119.4
Operating profit8.88.367.757.978.658.039.528.99
OPM %35.40%34.82%29.66%32.81%33.88%31.78%36.43%31.67%
Other income0.360.820.910.871.041.132.151.3
Interest00000.040.040.040.03
Depreciation0.340.360.350.40.470.520.660.45
Profit before tax8.828.828.318.449.188.610.979.81
Tax %26.64%26.08%24.07%25.71%27.23%23.37%26.98%25.59%
Net profit6.476.536.326.286.686.5987.3
EPS (₹)1.741.761.701.691.801.782.161.97

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Kronox Lab Sciences Ltd annual results

Kronox Lab Sciences Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales62829690100101105
Operating profit15202228333435
OPM %24%24%23%32%33%34%33%
Net profit10141621252829
EPS (₹)403.73565.564.425.756.867.457.71

TTM is the trailing twelve months to the most recent quarter.

Kronox Lab Sciences Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
10%
3 Years
2%
TTM
6%
Compounded Profit Growth
10 Years
%
5 Years
23%
3 Years
19%
TTM
12%
Stock Price CAGR
10 Years
%
5 Years
%
3 Years
%
1 Year
19%
Return on Equity
10 Years
%
5 Years
33%
3 Years
31%
Last Year
27%

Kronox Lab Sciences Ltd shareholding pattern

Promoters held 74.21% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.04% and DIIs 2.07%.

Kronox Lab Sciences Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters74.21%74.21%74.21%74.21%74.21%74.21%74.21%74.21%
FIIs0.56%0.49%0.05%0.03%0.03%0.05%0.08%0.04%
DIIs2.57%2.20%2.20%1.71%1.93%2.00%2.05%2.07%
Public22.66%23.10%23.54%24.04%23.84%23.74%23.66%23.68%
No. of shareholders39,79238,48937,92237,56935,78034,60833,46932,479

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Cruxal coverage of Kronox Lab Sciences Ltd

When is Kronox Lab Sciences Ltd’s AGM?

Kronox Lab Sciences Ltd’s annual general meeting is scheduled for 16 Sept 2026.

  • AGM17th Annual General Meeting and determination of dividend entitlement

See the full results calendar for every Indian company reporting in the next 30 days.

Kronox Lab Sciences Ltd corporate filings

  • Record Date for the purpose of Final Dividend as fixed by the Company is Wednesday, September 09, 2026Corp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited has officially announced Wednesday, September 09, 2026, as…

    Read the full analysis
  • In terms of Regulation 30 of SEBI (LODR) Regulations, 2015 please find enclosed Notice of 17th Annual General Meeting of Shareholders to be held on Wednesday, September 16, 2026.AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited has scheduled its 17th Annual General Meeting (AGM) for…

    Read the full analysis
  • Revised Submissoin of Annual Report for the year 2025-26Otherslow impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences has filed a revised version of its Annual Report for the financial…

    Read the full analysis
  • Anuual Report for the year 2025-26Otherslow impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Ltd has filed its Annual Report for the financial year 2025-26 as…

    Read the full analysis
  • The Company has received announcement in relation of public offer to the public shareholder of the Company issued by IIFL Capital Services Limited on behalf of Indo Borax & Chemical Limited ....Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited has received a public announcement for a mandatory open offer…

    Read the full analysis
  • IIFL Capital Services Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Public Announcement for the attention of the Public Shareholders of Kronox Lab Sciences Ltd ("Target ....Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Indo Borax and Chemicals Limited, along with Zenrock Chemicals Private Limited as a…

    Read the full analysis
  • Joint Press Release titled Indo Boarx to acquire 64.26% stake in Kronox Lab Sciences LimitedCompany Updatehigh impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited has announced that Indo Borax and Chemicals Ltd, along with…

    Read the full analysis
  • Promoters informed the Company about the SPA executed by them with Indo Borax & Chemicals Limited (Acquirer) and Zenrock Chemicals Private Limited (PAC)Company Updatemedium impact
    Filing PDF

    Cruxal's analysis: Promoters of Kronox Lab Sciences Ltd have executed a Share Purchase Agreement (SPA) with…

    Read the full analysis
  • Announcement of SPA executed by Promoter with Indo Borax & Chemicals Limited (Acquirer)and Zenrock Chemicals Privated Limited (PAC)Company Updatehigh impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited has announced that its promoters have entered into a Share…

    Read the full analysis
  • Newspaper Advt. for Unaudited Financial Results for the Quarter ended June 30, 2026Company Updatemedium impact
    Filing PDF
  • Record Date for the purpose of Final Dividend (if approved by Shareholders) will be Wednesday, September 09, 2026Corp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited has formally notified the stock exchanges regarding the…

    Read the full analysis
  • The Register of Members and Share transfer Book of the Company will remain closed from Thursday September 10, 2026 to Wednesday September 16, 2026 (both the days inclusive) for the purpose ....Corp. Actionlow impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Ltd has scheduled the closure of its Register of Members and Share…

    Read the full analysis
  • Board Meeting held today to consider and approve Unaudited Standalone Financial Results for the Quarter ended June 30, 2026 and fix date of AGM and Record Date.Board Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited reported standalone revenue from operations of 28.39 crore…

    Read the full analysis
  • Kronox Lab Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Standalone Financial ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Kronox Lab Sciences Limited has formally intimated the stock exchanges regarding a Board…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Kronox Lab Sciences Ltd

Cruxal reads every Kronox Lab Sciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Kronox Lab Sciences Ltd (KRONOX) Results, Financials & Share Price | Cruxal